Syndax Pharmaceuticals Earnings
NASDAQ: SNDXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Mon, Nov 2, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.51
Syndax Pharmaceuticals earnings summary
Syndax Pharmaceuticals is scheduled to report Sep/2026 earnings on Nov 2, 2026, with analysts expecting EPS of $-0.51. In its most recent report on Aug 4, 2026 (Q2 2026), SNDX posted EPS of $-0.55. Revenue for the quarter was $72.8 million.
Across the last 16 reports, SNDX shares moved an average of 8.9% (in either direction) in the first trading session after results, rising 5 times and falling 11 times.
Summary generated from market data by MetaCap's automated system. Methodology
SNDX earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 4, 2026 | — | $-0.55 | — | -2.7% |
| Apr 30, 2026 | — | $-0.48 | — | +12.5% |
| Jan 12, 2026 | — | $-0.78 | — | -1.3% |
| Nov 3, 2025 | — | $-0.70 | — | +10.5% |
| Aug 4, 2025 | — | $-0.83 | — | +26.1% |
| May 5, 2025 | — | $-0.98 | — | -15.4% |
| Mar 3, 2025 | — | $-1.09 | — | -3.5% |
| Nov 5, 2024 | — | $-0.98 | — | -27.4% |
| Aug 1, 2024 | — | $-0.80 | — | -4.8% |
| May 8, 2024 | — | $-0.85 | — | -6.7% |
| Feb 27, 2024 | — | $-1.02 | — | +3.6% |
| Nov 2, 2023 | — | $-0.73 | — | -8.4% |
| Aug 3, 2023 | — | $-0.64 | — | -6.2% |
| May 8, 2023 | — | $-0.59 | — | +2.9% |
| Feb 28, 2023 | — | $-0.63 | — | -9.0% |
| Nov 3, 2022 | — | $-0.58 | — | -1.1% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.